Cath lab IMV market report

Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more healthcare facilities look to replace aging equipment, according to a new report by IMV Medical Information Division. The census-based report finds that both patient volume and installed base are rising as the market recovers from a recent slowdown.

According to the KLAS report Clinical Market Share 2013: More than Meaningful Use, Cerner Corporation and Epic Systems combined captured more than three-fourths of new large-hospital electronic medical records (EMR) contracts, while the other vendors struggled to keep pace.

Immediate U.S. government furloughs affecting virtually all National Science Foundation (NSF) employees and three-fourths of those at the National Institutes of Health (NIH) could impact U.S. competitiveness, American Association for the Advancement of Science (AAAS) warned.

EndoCross, Ltd. announced today that it has already enrolled one-third of the patients planned for the first-in-human study of its Enabler-C Catheter System for Crossing Coronary Chronic Total Occlusions (“Enabler 3C” study). The Enabler 3C clinical study is taking place at the Institut Cardiovasculaire Paris-Sud under principal investigator Dr. Yves Louvard.

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter Inc. announced the U.S. Food and Drug Administration (FDA) clearance of its new Access AccuTnI+3 troponin I assay for use on the UniCel DxI series of immunoassay systems.

At RSNA 2013, GE Healthcare will showcase a range of molecular imaging tools designed to enable treatment evaluation earlier in a patient’s care pathway. Q.Suite, a collection of capabilities designed to extend quantitative positron emission tomography (PET) by generating more consistent standardized uptake value (SUV) readings, enabling clinicians to assess treatment response. Q.Suite is designed to help improve consistency of quantitative measurements in every key area: daily quality control, scanner workflow, motion correction, reconstruction algorithms and analysis and reporting applications. Controlling these variables to increase consistency can improve the clinician’s confidence that an SUV change has useful clinical meaning.

At RSNA 2013, GE will continue to demonstrate its innovations in low dose and high image quality in computed tomography (CT) imaging. The Discovery CT750 HD is the world's first high definition CT (HDCT), built with GE's exclusive Gemstone detector FREEdom Technologies. This allows for intelligent motion correction to “freeze” coronary motion, enhance coronary visualization and obtain additional information on plaque material composition. New this year is kV Assist, which provides optimized personalized scan settings and applications with automated kV and mA selection. kV Assist combined with SnapShot Assist deliver the desired image quality at the lowest possible dose and workflow optimizations for efficient cardiac CT.

When echocardiograms prove insufficient for diagnosis, Diagnosoft’s offers a patented and U.S. Food and Drug Administration 510(k)-cleared cardiac magnetic resonance imaging (CMR) solution for patient assessment. With benchmark sensitivity and specificity, the high throughput Diagnosoft CMR exam yields an advantageous alternative to nuclear or cardiac cath exams.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now